Illinois HB1102 mandates no cost-sharing for annual cervical, prostate, and ovarian cancer screenings for insureds.
Illinois HB1102 amends the Illinois Insurance Code to eliminate cost-sharing for specific cancer screenings. It requires no deductible, coinsurance, or copayment for annual cervical smear tests for all insureds, annual prostate cancer screenings for those recommended by a physician, and surveillance tests for ovarian cancer for those at risk. The Act takes effect January 1, 2027.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.